KAREN GREEN: Open Payments
NPI 1104382803 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 34 payments from 16 companies in 2025. Trend: 2023 $1,295 · 2024 $1,391 · 2025 $896
Food & beverage: $797Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $171 |
| PFIZER INC. | 1 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Biogen, Inc. | 3 | $72 |
| LivaNova USA, Inc. | 4 | $70 |
| Organon LLC | 4 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Journey Medical Corporation | 1 | $45 |
| UCB, Inc. | 1 | $41 |
| LEO Pharma Inc. | 1 | $39 |
Products named: OTEZLA, CIBINQO, DUPIXENT, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, TYSABRI, AUSTEDO XR, Bimzelx, PANZYGA.
Industry payments across TX — which companies pay providers there.
